A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 349 participants.
Also called NCT02110901
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 349 participants
- Sponsor
- Registry
-
NCT02110901
-
- Other papers using this trial's data
- A randomized trial of vonapanitase (PATENCY-1) to promote radiocephalic fistula patency and use for hemodialysis
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02110901. Randomized; quadruple masking; primary purpose treatment. Start 2014-07 (actual); primary completion 2016-12 (actual). Results posted on 2019-07-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1)
- Condition
- Chronic Kidney Disease
- Intervention (Drug)
- PRT-201
- Intervention (Drug)
- Placebo
- Lead sponsor
- Proteon Therapeutics
Record details
- Record id
cardio:ct-nct02110901- Content hash
f920e806126d0b9163a15442454a9cb4548469c8998e936d4dbadfc455dc0b80